MedPath
FDA Approval

Brimonidine Tartrate

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
February 19, 2013
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Brimonidine(2 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Physicians Total Care, Inc.

Physicians Total Care, Inc.

194123980

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Brimonidine Tartrate

Product Details

NDC Product Code
54868-6287
Application Number
ANDA076260
Marketing Category
ANDA (C73584)
Route of Administration
OPHTHALMIC
Effective Date
February 19, 2013
BENZALKONIUM CHLORIDEInactive
Code: F5UM2KM3W7Class: IACT
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACT
Code: 4S9CL2DY2HClass: ACTIBQuantity: 2 mg in 1 mL
WATERInactive
Code: 059QF0KO0RClass: IACT
POLYVINYL ALCOHOLInactive
Code: 532B59J990Class: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULRClass: IACT
© Copyright 2025. All Rights Reserved by MedPath
Brimonidine Tartrate - FDA Approval | MedPath